Comparison of Lanreotide and Octreotide LAR Use and Outcomes for Gastrointestinal Neuroendocrine Tumors in British Columbia, Canada.
Saved in:
| Title: | Comparison of Lanreotide and Octreotide LAR Use and Outcomes for Gastrointestinal Neuroendocrine Tumors in British Columbia, Canada. |
|---|---|
| Authors: | Paul A; BC Cancer, Vancouver, BC, Canada., Mendis S; BC Cancer, Vancouver, BC, Canada., Diaz-Stewart M; University of British Columbia, Vancouver, BC, Canada., Jao J; BC Cancer, Vancouver, BC, Canada., Boutin M; BC Cancer, Vancouver, BC, Canada., Safro M; BC Cancer, Vancouver, BC, Canada., Denault MH; BC Cancer, Vancouver, BC, Canada., Speers C; BC Cancer, Vancouver, BC, Canada., Stuart H; Vancouver General Hospital, Vancouver, BC, Canada., Gill S; BC Cancer, Vancouver, BC, Canada., Renouf DJ; BC Cancer, Vancouver, BC, Canada., Schaeffer DF; Vancouver General Hospital, Vancouver, BC, Canada., Farnell D; Vancouver General Hospital, Vancouver, BC, Canada., Loree JM; BC Cancer, Vancouver, BC, Canada. |
| Source: | Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2026 Jan-Dec; Vol. 33, pp. 10732748261417423. Date of Electronic Publication: 2026 Feb 19. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9438457 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-2359 (Electronic) Linking ISSN: 10732748 NLM ISO Abbreviation: Cancer Control Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1526-2359 |
|---|---|
| DOI: | 10.1177/10732748261417423 |
